Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSDAQ 203400Orphan Drug10 approvals2 trials

ABION Inc.

Official website

KOSDAQ-listed biotech developing biomarker-driven targeted cancer therapies including lead candidate Vabametkib (ABN401).

As of 2026-10-10, ABION Inc. has 9 Korean MFDS device approvals, 42 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2007 and listed on KOSDAQ in 2021, ABION is a companion-diagnostics-based anticancer drug developer. Its pipeline includes Vabametkib (ABN401), a targeted therapy for non-small cell lung cancer, ABN501, an antibody platform targeting Claudin3, ABN202, an antibody-cytokine fusion protein platform, and ABN101, an interferon-beta based broad-spectrum antiviral therapeutic. It discovers biomarkers to use in patient selection, combination therapy design, and resistance-mechanism analysis, aiming to raise clinical success rates and commercial value.

Regulatory approvals

data.go.kr

1 Orphan Drug designations · 2025 / 9 Korean MFDS device approvals · 2001–2015

  • Orphan바바메킵2025-08-13
    Orphan Drug designation · in development20250046982
  • MFDSSchirmer stripRevoked2015-04-20
    Product approval · Class 1서울 수신 15-790 호
  • MFDSTelemetry system transmitter, analysisRevoked2004-07-09
    Product approval · Class 2제허 04-738 호
  • MFDS의료용영상처리용장치소프트웨어Revoked2002-11-07
    Product approval · Class 2제허 02-867 호
  • MFDS의료용영상처리용장치소프트웨어Revoked2002-07-02
    Product approval · Class 2제허 02-561 호
  • MFDS의료용영상처리용장치소프트웨어Revoked2002-07-02
    Product approval · Class 2제허 02-562 호
  • MFDS의료용영상처리용장치소프트웨어Revoked2002-07-02
    Product approval · Class 2제허 02-563 호
  • MFDS의료용영상처리용장치소프트웨어Revoked2002-07-02
    Product approval · Class 2제허 02-564 호
  • MFDS의료용영상처리용장치소프트웨어Revoked2002-06-08
    Product approval · Class 2제허 02-482 호
  • MFDS의료용영상처리용장치소프트웨어Revoked2001-12-12
    Product approval · Class 2제허 01-728 호

Clinical trials

data.go.kr

2 MFDS clinical trial authorisations · 2021–2022 (Phase 2 1 · Phase 1 1)

  • Phase 2ABN401정(바바메킵), 레이저티닙2022-10-21

    29 trial sites

  • Phase 1ABN401정(바바메킵), 레이저티닙2021-11-24

    3 trial sites

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

바바메킵(Vabametkib, ABN401) · 비소세포폐암(NSCLC) · Biomarker-driven targeted therapy for non-small cell lung cancer

ABN501 · 고형암(Claudin3 발현) · Antibody platform targeting Claudin3

ABN202 · Antibody-cytokine fusion protein platform technology

ABN101 · 바이러스 감염 · Interferon-beta based broad-spectrum antiviral therapeutic

Key disclosures

KRX KIND via OpenDART
Show 15 more events

Publications

PubMed · affiliation-matched
Show 32 more publications

Patents

KIPRIS · applicant-matched
Show 148 more patents

AI reads

MAA server logs · IP-verified
128
Times AI engines pulled ABION Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

127
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

15
live 1
Last 7 days
66
live 1
Last 30 days
128
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot80
  • GoogleGoogleOther37
  • PerplexityPerplexityBot7
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 25, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for ABION Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · products. Send us materials and we will add them

Companies approved for the same productsBiotech & Drug Discovery

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

INFINITT Healthcare Co., Ltd.2 shared

Founded in 2002, INFINITT Healthcare provides PACS-centered medical imaging software and AI diagnostic aids across multiple clinical specialties.

BITComputer1 shared

Founded in 1985, BITComputer provides hospital information systems such as bitnixHIS and CLEMR, alongside digital healthcare and IT education businesses.

JW PHARMACEUTICAL1 shared

Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.

RAYENCE CO.,LTD.1 shared

KOSDAQ-listed X-ray imaging solution company with a full lineup of medical, dental, veterinary, and industrial X-ray detectors.

SHINHUNG CO.,LTD1 shared

Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.

ValueAddedTechnologyCo.,Ltd.1 shared

Founded in 1992 and KOSDAQ-listed in 2006, VATECH manufactures dental digital X-ray and CT imaging diagnostic devices.

Vieworks Co., Ltd.1 shared

Vieworks, founded in 1999 and KOSDAQ-listed in 2009, develops X-ray detectors and industrial camera imaging solutions.

AHNLAB,INC.100

KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.

Inventage Lab Inc.100

Drug delivery system company behind the long-acting injectable platform IVL-DrugFluidic and the LNP delivery platform IVL-GeneFluidic.

ORGANOIDSCIENCES LTD.100

Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.

Eone Diagnomics Genome Center Co., Ltd.85

EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.

SK Chemicals Co., Ltd.85

A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition